Gluten Intolerance Treatment Market to Reach US$ 2.5 Billion by 2034, Growth at CAGR 13.9% | Report by Transparency Market Research, Inc.

The rising diagnosis rates of gluten intolerance and celiac disease globally are a significant factor driving the market. Awareness of these conditions has increased, leading to more people seeking treatment and dietary solutions.

WILMINGTON, Del., July 22, 2024 /PRNewswire/ -- The gluten intolerance treatment market was projected to attain US$ 593.5 million in 2023. It is likely to garner a 13.9% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 2.5 billion.

The gluten-free food and beverage sector is expanding rapidly, driven by consumer demand for gluten-free alternatives. This growth supports the gluten intolerance treatment market by providing more dietary options for affected individuals. There is a continuous innovation in the formulation of gluten-free products, aiming to improve taste, texture, and nutritional value. This trend is making gluten-free diets more appealing and sustainable for consumers.

Personalized treatment plans and precision medicine are becoming more common, tailored to individual genetic profiles and specific needs, enhancing treatment efficacy for gluten intolerance. The rise of e-commerce and online retail platforms has made gluten-free products more accessible to a broader audience, contributing to market growth.

Request a PDF Sample of this Report Now!

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86215 

Investment in the development of new pharmaceutical treatments, such as enzyme supplements that can break down gluten or drugs that can modify the immune response, presents a considerable opportunity. Increasing educational campaigns about gluten intolerance, its symptoms, and management strategies can lead to higher diagnosis rates and greater market demand.

Leveraging biotechnology to create innovative products, such as genetically modified grains that are safe for gluten-intolerant individuals, could revolutionize the market. The increasing availability of gluten-free options in restaurants and fast-food chains is making it easier for individuals with gluten intolerance to adhere to their dietary needs, thereby increasing market demand.

Gluten Intolerance Treatment Market Report Scope:

Key Findings of Market Report

• There is ongoing research into non-dietary therapies such as vaccines, probiotics, and microbiome therapies, which could offer alternative treatment options and expand the market.
• Consumers are increasingly demanding transparency regarding ingredients and quality in gluten-free products, pushing manufacturers to improve their product offerings.
• Advancements in food technology, such as better gluten substitutes and improved manufacturing processes, are enhancing the quality and variety of gluten-free products.
• Utilizing AI to predict and diagnose gluten intolerance more accurately can lead to earlier intervention and better management, boosting market growth.

Market Trends for Gluten Intolerance Treatment

• By drug type, the antihistamines segment is expected to boost the growth of the gluten intolerance treatment market.
• Antihistamines are used to manage allergic reactions, including those triggered by gluten intolerance.
• They can help alleviate symptoms such as itching, rash, and swelling, which are common in individuals with gluten sensitivity or allergic reactions.
• With improved awareness and diagnostic capabilities for gluten intolerance, more individuals are seeking symptomatic relief, driving demand for antihistamines as part of their treatment regimen.
• In terms of indication, the celiac disease segment is anticipated to accelerate the market growth.
• There is a growing awareness and improved diagnostic techniques for celiac disease, leading to more accurate and earlier diagnosis of the condition.

Unlock Growth Potential in Your Industry! Download PDF Brochure:  https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86215 

Global Market for Gluten Intolerance Treatment: Regional Outlook

North America

• North America has a relatively high prevalence of celiac disease and gluten sensitivity.
• The increasing diagnosis rates in the region drive the demand for gluten intolerance treatments.
• There is a growing awareness among healthcare providers and the general population about gluten intolerance, leading to improved diagnosis rates.
• Increased awareness encourages more individuals to seek medical advice and treatment options.

Asia Pacific

• Global dietary trends, including the adoption of gluten-free diets, are increasingly influencing Asia Pacific countries.
• This shift is fueled by health consciousness, rising disposable incomes, and a growing middle-class population.
• Many countries in Asia Pacific are investing in healthcare infrastructure development, improving access to healthcare services, diagnostic facilities, and specialty clinics that cater to gastrointestinal disorders, including gluten intolerance.

Gluten Intolerance Treatment Market: Key Players

The competitive landscape of the gluten intolerance treatment market is characterized by a mix of pharmaceutical companies, biotechnology firms, food manufacturers, and specialty product providers.

The market is competitive due to the rising prevalence of gluten intolerance and celiac disease, increasing consumer awareness, and demand for effective treatments and gluten-free products. The following companies are well known participants in the gluten intolerance treatment market:

• Precigen ActoBio
• Calypso Biotech SA
• Alvine Pharmaceuticals Inc.
• ImmusanT
• Artielle ImmunoTherapeutics
• FunZyme Biotechnologies
• Innovative BioPharma
• AMYRA Biotech AG
• Vactech Composites Pvt. Ltd.
• Alba Therapeutics Corporation
• PvP Biologics Inc.

Key Development

• In 2023, Amgen filed a patent outlining a method for treating celiac disease, also referred to as non-celiac gluten sensitivity, using an antigen-binding fragment or an anti-IL-15 antibody.

Gluten Intolerance Treatment Market Segmentation 

Drug Type

• Antihistamines
• Epinephrine

Indication

• Celiac Disease
• Dermatitis Herpetiformis
• Depression
• Gluten Ataxia

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=86215&ltype=S 

More Trending Reports by Transparency Market Research:

• Vendor Neutral Archive (VNA) Market - The global vendor neutral archive (VNA) market is projected to advance at a CAGR of 12.6% from 2024 to 2034
• Interleukins Market - The global interleukins market is projected to expand at a CAGR of 15.9% during the forecast period from 2024 to 2034
• Medical Tubing Market - Ongoing advancements in material science offer lucrative opportunities to market players. Manufacturers are focusing on introducing innovative materials in order to increase market revenue.
• Tumor Ablation Market is estimated to grow at a CAGR of 6.9% from 2023 to 2031 and reach US$ 2.3 Bn by the end of 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com   

Email: sales@transparencymarketresearch.com

Follow Us: LinkedIn| Twitter| Blog | YouTube

Logo - https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg